{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:51:55Z","timestamp":1784289115496,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bcp.2021.114440","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T12:32:41Z","timestamp":1612269161000},"page":"114440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["His452Tyr polymorphism in the human 5-HT2A receptor affects clozapine-induced signaling networks revealed by quantitative phosphoproteomics"],"prefix":"10.1016","volume":"185","author":[{"given":"Sandra M.","family":"Mart\u00edn-Guerrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cimadevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Brea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mart\u00edn-Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro R.","family":"Cutillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gonz\u00e1lez-Maeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"L\u00f3pez-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114440_b0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","article-title":"Mechanisms of signalling and biased agonism in G protein-coupled receptors","volume":"19","author":"Wootten","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2021.114440_b0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1242\/jcs.115.3.455","article-title":"The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals","volume":"115","author":"Luttrell","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2021.114440_b0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/BJ20041361","article-title":"Monitoring the formation of dynamic G-protein-coupled receptor\u2013protein complexes in living cells","volume":"385","author":"Pfleger","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2021.114440_b0020","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","author":"Lopez-Gimenez","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.bcp.2021.114440_b0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jad.2011.04.043","article-title":"Receptor targets for antidepressant therapy in bipolar disorder: an overview","volume":"138","author":"Fountoulakis","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bcp.2021.114440_b0030","doi-asserted-by":"crossref","DOI":"10.1517\/13543784.2013.769957","article-title":"5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders","author":"Mestre","year":"2013","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bcp.2021.114440_b0035","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-017-0552-9","article-title":"Clozapine as a model for antipsychotic development","author":"Nucifora","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bcp.2021.114440_b0040","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-25761-2_4","article-title":"Serotonergic mechanisms as targets for existing and novel antipsychotics","author":"Meltzer","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2021.114440_b0055","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/npp.2014.38","article-title":"Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a betaarrestin2-independent activation of Akt","volume":"39","author":"Schmid","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2021.114440_b0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0920-9964(98)00032-2","article-title":"Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response","volume":"32","author":"Arranz","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bcp.2021.114440_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.euroneuro.2015.12.035","article-title":"Pharmacogenetics of clozapine response and induced weight gain: a comprehensive review and meta-analysis","volume":"26","author":"Gressier","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0070","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/emboj\/21.10.2332","article-title":"Synaptic multiprotein complexes associated with 5-HT(2C) receptors: a proteomic approach","volume":"21","author":"Becamel","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2021.114440_b0075","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1124\/mol.66.5.1293","article-title":"His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation","volume":"66","author":"Hazelwood","year":"2004","journal-title":"Mol Pharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0080","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/mol.108.048272","article-title":"Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation","volume":"74","author":"Lopez-Gimenez","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0085","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1124\/mol.106.033035","article-title":"The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function","volume":"71","author":"Lopez-Gimenez","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-019-0391-9","article-title":"Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring","author":"Hijazi","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2021.114440_b0095","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41375-018-0032-1","article-title":"Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells","volume":"32","author":"Casado","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2021.114440_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","author":"Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bcp.2021.114440_b0105","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2021.114440_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw419","article-title":"Heatmapper: web-enabled heat mapping for all","author":"Babicki","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2021.114440_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw3122","article-title":"Interclass GPCR heteromerization affects localization and trafficking","volume":"13","author":"Toneatti","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bcp.2021.114440_b0120","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1046\/j.1471-4159.1997.68052186.x","article-title":"A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization","volume":"68","author":"Ozaki","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2021.114440_b0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/JMN:26:2-3:253","article-title":"Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity","volume":"26","author":"Luttrell","year":"2005","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2021.114440_b0130","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00213-014-3608-0","article-title":"The activation of the Akt\/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect","volume":"231","author":"Smith","year":"2014","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.euroneuro.2017.02.005","article-title":"Clozapine as the most efficacious antipsychotic for activating ERK 1\/2 kinases: Role of 5-HT2A receptor agonism","volume":"27","author":"Aringhieri","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-5793(04)00082-1","article-title":"The effects of clozapine on the GSK-3-mediated signaling pathway","author":"Kang","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2021.114440_b0145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cell.2018.07.003","article-title":"Akt kinase activation mechanisms revealed using protein semisynthesis","volume":"174","author":"Chu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2021.114440_b0150","doi-asserted-by":"crossref","first-page":"16729","DOI":"10.1074\/jbc.RA119.010036","article-title":"Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes","volume":"294","author":"Kearney","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114440_b0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tibs.2018.02.006","article-title":"Genetic vulnerability of GPCRs: a call to action","volume":"43","author":"Liggett","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bcp.2021.114440_b0160","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/BF02281871","article-title":"Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia","volume":"97","author":"Erdmann","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bcp.2021.114440_b0165","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.cellsig.2013.01.004","article-title":"Attenuated PLD1 association and signalling at the H452Y polymorphic form of the 5-HT(2A) receptor","volume":"25","author":"Barclay","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2021.114440_b0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.tpj.6500342","article-title":"Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies","volume":"6","author":"Davies","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.bcp.2021.114440_b0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2011.03.038","article-title":"Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor","volume":"659","author":"Lukasiewicz","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00008571-200302000-00007","article-title":"Human genetic variations in the 5HT2A receptor: a single nucleotide polymorphism identified with altered response to clozapine","volume":"13","author":"Harvey","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2021.114440_b0185","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.mp.4001495","article-title":"Inter-relationships of intermediate phenotypes for serotonin function, impulsivity, and a 5-HT2A candidate allele: His452Tyr","volume":"9","author":"Reist","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bcp.2021.114440_b0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.1998.tb10187.x","article-title":"Activation of the mitogen-activated protein kinase pathway via the 5-HT2A receptor","volume":"861","author":"Watts","year":"1998","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.bcp.2021.114440_b0195","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","article-title":"A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases","volume":"86","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2021.114440_b0200","doi-asserted-by":"crossref","first-page":"17194","DOI":"10.1074\/jbc.M801713200","article-title":"Activation of 5-HT2A\/C receptors counteracts 5-HT1A regulation of N-methyl-d-aspartate receptor channels in pyramidal neurons of prefrontal cortex","volume":"283","author":"Yuen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114440_b0205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00210-008-0378-4","article-title":"Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors","volume":"379","author":"Knauer","year":"2009","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114440_b0210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by beta-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science (80-)"},{"key":"10.1016\/j.bcp.2021.114440_b0215","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1073\/pnas.0708862105","article-title":"Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo","volume":"105","author":"Schmid","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2021.114440_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4927","article-title":"In vivo brain GPCR signaling elucidated by phosphoproteomics","volume":"360","author":"Liu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bcp.2021.114440_b0225","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20198828","article-title":"Elucidating essential kinases of endothelin signalling by logic modelling of phosphoproteomics data","author":"Sch\u00e4fer","year":"2019","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bcp.2021.114440_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54502-6","article-title":"Phosphoproteomic analysis sheds light on intracellular signaling cascades triggered by formyl-peptide receptor 2","author":"Cattaneo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2021.114440_b0235","article-title":"Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function","author":"Lin","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2021.114440_b0240","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1074\/jbc.RA119.012026","article-title":"Phosphoproteomic characterization of the signaling network resulting from activation of the chemokine receptor CCR2","volume":"295","author":"Huang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114440_b0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41398-019-0519-1","article-title":"Clozapine-dependent inhibition of EGF\/neuregulin receptor (ErbB) kinases","volume":"9","author":"Kobayashi","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bcp.2021.114440_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4522(98)00653-8","article-title":"Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo","author":"Willins","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2021.114440_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/v11050450","article-title":"Inhibition of epstein-barr virus lytic reactivation by the atypical antipsychotic drug clozapine","author":"Anderson","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2021.114440_b0260","doi-asserted-by":"crossref","DOI":"10.3109\/10401230109148955","article-title":"Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment","author":"Dwyer","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.bcp.2021.114440_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.22864","article-title":"Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped\/Pea-15 protein abundance","author":"Panariello","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2021.114440_b0270","doi-asserted-by":"crossref","DOI":"10.4161\/cc.8.16.9335","article-title":"The Akt kinases: isoform specificity in metabolism and cancer","volume":"8","author":"Gonzalez","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2021.114440_b0275","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.psyneuen.2019.01.029","article-title":"Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons","volume":"104","author":"Kowalchuk","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bcp.2021.114440_b0280","article-title":"Direct effects of antipsychotic drugs on insulin, energy sensing and inflammatory pathways in hypothalamic mouse neurons","author":"Kowalchuk","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bcp.2021.114440_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00344","article-title":"Ribosomal protein S6 hypofunction in postmortem human brain links mTORC1-dependent signaling and schizophrenia","author":"Ibarra-Lecue","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:24:08Z","timestamp":1757769848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":57,"alternative-id":["S0006295221000368"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114440","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"His452Tyr polymorphism in the human 5-HT2A receptor affects clozapine-induced signaling networks revealed by quantitative phosphoproteomics","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114440"}}